Nexalin Technology Inc Warrant
NXLIW
NXLIW was delisted on the 19th of September, 2025.
7 hedge funds and large institutions have $93.3K invested in Nexalin Technology Inc Warrant in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
15% more capital invested
Capital invested by funds: $81.2K → $93.3K (+$12.1K)
0.03% less ownership
Funds ownership: 10.37% → 10.34% (-0.03%)
13% less funds holding
Funds holding: 8 → 7 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$107 |
| 2 |
CS
Clear Street
New York
|
-$38 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9 |
NXLIW Hedge Fund Activity: Q2 2023 in Review
7 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology Inc Warrant (NXLIW) for Q2 2023, worth a combined $93.3K — up 15% from $81.2K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NXLIW and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.
The largest seller was Citadel Advisors, cutting an estimated $107.
- 7 institutional investors held Nexalin Technology Inc Warrant (NXLIW) as of Q2 2023, down from 8 in Q1 2023.
- Funds reported $93.3K of Nexalin Technology Inc Warrant stock for Q2 2023, up 15% quarter-over-quarter.
- 0 funds opened new Nexalin Technology Inc Warrant positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest Nexalin Technology Inc Warrant seller in Q2 2023 was Citadel Advisors, an estimated $107 sold.
Based on aggregated 13F filings for Q2 2023.